Evidence map›Paper›PMID 38900207›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

A comparative study of large language model-based zero-shot inference and task-specific supervised classification of breast cancer pathology reports.

Madhumita Sushil, Travis Zack, Divneet Mandair, Zhiwei Zheng, Ahmed Wali, Yan-Ning Yu, Yuwei Quan, Dmytro Lituiev, Atul J Butte

Abstract readComparative Study
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. An Implemented Real-World-Data Pipeline for Standardization of Electronic Health Records in Precision Oncology.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Madhumita SushilBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94158, United States.ORCID 0000-0001-7884-0526
Travis ZackBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94158, United States.
Divneet MandairBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94158, United States.
Zhiwei ZhengUniversity of California, Berkeley, Berkeley, CA 94720, United States.
Ahmed WaliUniversity of California, Berkeley, Berkeley, CA 94720, United States.
Yan-Ning YuUniversity of California, Berkeley, Berkeley, CA 94720, United States.
Yuwei QuanUniversity of California, Berkeley, Berkeley, CA 94720, United States.
Dmytro LituievBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94158, United States.ORCID 0000-0003-0543-0758
Atul J ButteBakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, CA 94158, United States.

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
UCSF-Stanford Center of Excellence in Regulatory Science and InnovationU01FD005978 · FDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALTMAN, RUSS BIAGIO, GIACOMINI, KATHLEEN M · 2016 to 2025
$34.5M
FDA HHS U01 FD005978FDA HHS U01FD005978NCATS NIH HHS UL1 TR001872NCI NIH HHS P30 CA082103NIH HHS P30CA082103NIH HHS UL1 TR001872UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation
6 · The paper itself

Abstract

objectiveAlthough supervised machine learning is popular for information extraction from clinical notes, creating large annotated datasets requires extensive domain expertise and is time-consuming. Meanwhile, large language models (LLMs) have demonstrated promising transfer learning capability. In this study, we explored whether recent LLMs could reduce the need for large-scale data annotations. MATERIALS AND

methodsWe curated a dataset of 769 breast cancer pathology reports, manually labeled with 12 categories, to compare zero-shot classification capability of the following LLMs: GPT-4, GPT-3.5, Starling, and ClinicalCamel, with task-specific supervised classification performance of 3 models: random forests, long short-term memory networks with attention (LSTM-Att), and the UCSF-BERT model.

resultsAcross all 12 tasks, the GPT-4 model performed either significantly better than or as well as the best supervised model, LSTM-Att (average macro F1-score of 0.86 vs 0.75), with advantage on tasks with high label imbalance. Other LLMs demonstrated poor performance. Frequent GPT-4 error categories included incorrect inferences from multiple samples and from history, and complex task design, and several LSTM-Att errors were related to poor generalization to the test set. DISCUSSION: On tasks where large annotated datasets cannot be easily collected, LLMs can reduce the burden of data labeling. However, if the use of LLMs is prohibitive, the use of simpler models with large annotated datasets can provide comparable results.

conclusionsGPT-4 demonstrated the potential to speed up the execution of clinical NLP studies by reducing the need for large annotated datasets. This may increase the utilization of NLP-based variables and outcomes in clinical studies.

Indexed as

Breast NeoplasmsSupervised Machine LearningData MiningDatasets as TopicElectronic Health RecordsFemaleHumansNatural Language Processingbreast cancerelectronic health recordslarge language modelsnatural language processingpathology

Identifiers

PMID38900207
PMCPMC11413420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.